Elsevier

The Lancet

Volume 338, Issue 8771, 5 October 1991, Pages 842-847
The Lancet

Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure

https://doi.org/10.1016/0140-6736(91)91501-KGet rights and content

Abstract

The frequency of non-insulin-dependent diabetes mellitus (NIDDM) and of high blood pressure (or hypertension) is higher in some ethnic groups than in others for reasons that remain unclear. To investigate the mechanisms leading to these ethnic differences, plasma C-peptide and insulin concentrations were measured after overnight fast and during an oral glucose tolerance test in subjects aged 45-74 years sampled from the practice lists of two north west London health centres. Ethnic group was defined by grandparental origin as Afro-Caribbean in 106, Gujerati Indian in 107, and white European in 101. The total age-adjusted prevalence of NIDDM was 29% in the Afro-Caribbean, 30% in the Gujerati, and 3% in the white groups, respectively. Fasting C-peptide and insulin concentrations increased from the subgroup with normal glucose tolerance, through impaired glucose tolerance, to new NIDDM, and were lower again in subjects with known NIDDM. The odds ratio for new NIDDM was 1·87 (95% confidence interval 1·26-2·77) per 1 SD increase in fasting C-peptide, which was the most powerful independent indicator of new NIDDM (p=0·0005) and accounted for the effect of ethnic group. Fasting insulin had a similarly strong effect. There was no relation between any index of insulin secretion and blood pressure or hypertension. There were differences among the ethnic groups in the C-peptide response relative to the insulin response. These results suggest that factors determining insulin secretion and its hepatic clearance, possibly including dietary fat, are the main causes of ethnic variation in rates of new NIDDM.

References (31)

  • Jk Cruickshank

    Diabetes: contrasts between people of black (West African), Indian subcontinent and white (European) origin

  • Nps Verma et al.

    The prevalence of known diabetes in an urban Indian environment

    Br Med J

    (1986)
  • Sa Alleyne et al.

    Mortality from diabetes in Jamaica

    Bull Pan Am Health Org

    (1989)
  • Jk Cruickshank et al.

    Glucose tolerance in North-West London: the prevalence and inheritance of diabetes by ethnic group with suggestions for prevention

    Diabetic Med

    (1990)
  • Gm Reaven

    Role of insulin resistance in human disease

    Diabetes

    (1988)
  • Cited by (149)

    • Haemostatic factors, lipoproteins and long-term mortality in a multi-ethnic population of Gujarati, African-Caribbean and European origin

      2014, Atherosclerosis
      Citation Excerpt :

      Individuals with known diabetes were not included. The methodology for the measurement of the anthropometric indices presented here has been described previously [40]. The Northwick Park and Central Middlesex Hospital committees granted ethical permission for all baseline measurements and mortality follow-up.

    • Anthropometry: A new approach to identify communal body fat status in an urban south Indian population

      2013, Obesity Research and Clinical Practice
      Citation Excerpt :

      Categorical risk factors of cardiovascular or hyperinsulinaemia occurred in Asian Indians, while BMI claims their health to be normal. High prevalent nature of hyperinsulinaemia had been alerted by studies in both urban and migrant Asian Indians; [19–21] and Cardiac autonomic neuropathy in diabetes, called as “Silent Killer” [22], could also be lethal though it can be diagnosed by Dynamic Pupillometry [23]. AEI never exposed much difference in gender classification of study subjects.

    • Validation of an enzyme-linked immunosorbent assay for C-peptide analysis in Cameroon

      2012, Diabetes Research and Clinical Practice
      Citation Excerpt :

      We excluded for prediabetes by considering only subjects with fasting plasma glucose levels of <100 mg/dL and a normal status following the oral glucose tolerance test (OGTT). Following an OGTT, Cruickshank et al. showed that C-peptide levels increased from normoglycemic subjects to those with impaired glucose tolerance and further in those newly diagnosed with type 2 diabetes [25]. The mean fasting Cameroonian C-peptide level (1.14 μg/L), however, was similar to the one (1.10 μg/L) reported by a Danish group [26].

    • Role of Ethnicity in Cardiovascular Disease: Lessons Learned from MESA and Other Population-Based Studies

      2011, Preventive Cardiology: Companion to Braunwald's Heart Disease Expert Consult - Online and Print
    View all citing articles on Scopus
    View full text